XML 25 R2.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2015
Dec. 31, 2014
Current assets:    
Cash $ 3,601 $ 12,424
Prepaid expenses $ 63,122 29,991
Settlement receivable 18,000
Deposits and other receivables $ 1,183 1,183
Total current assets 67,906 61,598
Property and equipment, net 70,767 96,255
Total Assets 138,673 157,853
Current liabilities:    
Accounts payable and accrued expense 204,167 191,967
Convertible notes payable, net of discounts of $62,083 and $14,148 37,917 10,852
Convertible notes payable, related parties, net of discounts of $-0- and $15,064 9,000 22,936
Convertible notes payable, in default 366,300 341,300
Convertible notes payable, in default - related parties 167,500 129,500
Convertible notes payable, at fair value 203,766 761,677
Shareholder loan 2,920 3,500
Notes payable, in default 30,000 30,000
Notes payable, in default - related parties 7,500 7,500
Total current liabilities $ 1,029,070 $ 1,499,232
Stockholders' deficit:    
Preferred stock, $0.0001 par values - 50,000,000 shares authorized; 67 shares issued; Series A - 7 shares issued and outstanding at September 30, 2015 and December 31, 2014; Series B - 60 shares issued and outstanding at September 30, 2015 and December 31, 2014
Common stock, $0.0001 par value - 1,200,000,000 shares authorized; 1,253,702,348 and 986,356,130 shares issued and outstanding at September 30, 2015 and December 31, 2014 $ 125,370 $ 98,636
Additional paid-in capital 9,895,592 8,734,606
Accumulated deficit (10,911,359) (10,174,621)
Total stockholders' deficit (890,397) (1,341,379)
Total liabilities and stockholders' deficit $ 138,673 $ 157,853
Series A    
Stockholders' deficit:    
Preferred stock, $0.0001 par values - 50,000,000 shares authorized; 67 shares issued; Series A - 7 shares issued and outstanding at September 30, 2015 and December 31, 2014; Series B - 60 shares issued and outstanding at September 30, 2015 and December 31, 2014
Series B    
Stockholders' deficit:    
Preferred stock, $0.0001 par values - 50,000,000 shares authorized; 67 shares issued; Series A - 7 shares issued and outstanding at September 30, 2015 and December 31, 2014; Series B - 60 shares issued and outstanding at September 30, 2015 and December 31, 2014